[1] 姜黎, 赵森, 周爱华, 等.中药与华法林之间药物相互作用分析. 中国中医药现代远程教育, 2020, 18:142-145.
[2] 顾敏, 顾翔. 老年非瓣膜性房颤患者华法林抗凝强度的研究进展. 中华老年多器官疾病杂志, 2019, 18: 232-236.
[3] Gabbi C, Bertolotti M. Drug-induced liver injury-types and phenotypes. New Engl J Med, 2019, 381: 1395-1396.
[4] Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology, 2015, 148: 1340-1352.
[5] Yasuda K, Asou M, Asakawa T, et al. Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report. J Med Case Rep, 2020, 14: 192.
[6] Casale M, Picariello S, Corvino F, et al. Life-threatening drug-induced liver injury in a patient with beta-thalassemia major and severe iron overload on polypharmacy. Hemoglobin, 2018, 42: 213-216.
[7] 刘维, 李璐, 胥婕, 等.1例华法林诱导的严重自身免疫性肝炎的药学监护. 北京大学学报(医学版), 2016, 48: 183-186.
[8] Zhu LQ, Jiang WT, Pan C, et al. Liver injury possibly related to drug interaction after liver transplant: a case report. J Clin Pharm Ther, 2014, 39: 439-441.
[9] 兰安杰, 丁春雷 ,罗静, 等. 氟康唑注射液与华法林片合用致药物性肝损伤及凝血功能异常1例. 中国药物警戒, 2011, 8: 61-62.
[10] Liakoni E, Ratz Bravo AE, Krahenbuhl S. Hepatotoxicity of new oral anticoagulants (NOACs). Drug Saf, 2015, 38: 711-720.
[11] Alonso A, MacLehose RF, Chen L Y, et al. Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation. Heart, 2017, 103: 834-839.
[12] Zhao JX, Blais Joseph E, Chui Celine SL, et al. Association between nonvitamin K antagonist oral anticoagulants or warfarin and liver injury: a cohort study. Am J Gastroenterol, 2020, 115: 1513-1524.
[13] 石磊, 罗琳, 石焱. 某三甲医院患者应用华法林对肝功能影响分析. 临床军医杂志, 2017, 45: 88-90.
[14] 吴婷,吕小琴.华法林致药物性肝损伤报告分析.中国药物警戒:1-7.
[15] Bjornsson HK, Gudmundsson DO, Bjornsson ES. Liver injury caused by oral anticoagulants: A population-based retrospective cohort study. Liver Int, 2020, 40: 1895-1900.
[16] 张振洋. 药物性肝炎68例临床特征分析. 郑州大学, 2014.
[17] Saif MW. An adverse interaction between warfarin and fluoropyrimidines revisited. Clin Colorectal Cancer, 2005, 5:175-180.
[18] Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. New Engl J Med, 2005, 352: 2285-2293.
[19] Intagliata NM, Henry ZH, Maitlad H, et al. Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation. Dig Dis Sci, 2016, 61: 1721-1727. |
